Page 68 - GPD-4-1
P. 68
Gene & Protein in Disease rs670 SNP in APOA1 gene
doi: 10.1093/AJCN/87.6.1926 Ebrahim GA. Re-sequencing of the APOAI promoter region
and the genetic association of the -75G > A polymorphism
43. All Variants in the APOA1 Gene - Global Variome Shared with increased cholesterol and low density lipoprotein levels
LOVD. Available from: https://databases.lovd.nl/shared/ among a sample of the Kuwaiti population. BMC Med Genet.
variants/APOA1 [Last accessed on 2024 Jun 26].
2013;14(1):1-11.
44. RefSNP Report - dbSNP - NCBI - rs28931573. Available from:
https://www.ncbi.nlm.nih.gov/snp/rs28931573#clinical_ doi: 10.1186/1471-2350-14-90/TABLES/5
significance [Last accessed on 2024 Jun 26]. 54. Rudkowska I, Dewailly E, Hegele RA, et al. Gene-diet
interactions on plasma lipid levels in the Inuit population.
45. Weisgraber KH, Rall SC, Bersot TP. Apolipoprotein Br J Nutr. 2013;109(5):953-961.
A-IMilano. Detection of normal A-I in affected subjects
and evidence for a cysteine for arginine substitution in the doi: 10.1017/S0007114512002231
variant A-I. J Biol Chem. 1983;258(4):2508-2513. 55. Song YY, Gong RR, Zhang Z, et al. Effects of apolipoprotein
doi: 10.1016/S0021-9258(18)32955-7 A1 Gene rs670 and rs5069 polymorphisms on the plasma
lipid profiles in healthy adolescents with different body
46. Halley P, Kadakkuzha BM, Faghihi MA, et al. Regulation of mass index. Zhongguo Yi Xue Ke Xue Yuan Xue Bao.
the apolipoprotein gene cluster by a long noncoding RNA. 2014;36(4):369-376.
Cell Rep. 2014;6(1):222-230.
doi: 10.3881/J.ISSN.1000-503X.2014.04.005
doi: 10.1016/J.CELREP.2013.12.015
56. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS,
47. Luis DA de, Izaola O, Primo D, et al. Influencia de la variante et al. Dietary patterns interact with APOA1/APOC3
rs670 del gen APOA1 en la respuesta HDL sérica a una polymorphisms to alter the risk of the metabolic
dieta hipocalórica enriquecida con grasas poliinsaturadas syndrome: The Tehran Lipid and Glucose Study. Br J Nutr.
frente a una enriquecida con grasas monoinsaturadas. Nutr 2015;113(4):644-653.
Hosp. 2019;36(6):1288-1295.
doi: 10.1017/S0007114514003687
doi: 10.20960/NH.02390
57. Włodarczyk M, Wrzosek M, Nowicka G, Jabłonowska-
48. Hsu MC, Lee KT, Hsiao WC, et al. The dyslipidemia- Lietz B. Impact of variants in CETP and apo AI genes on
associated SNP on the APOA1/C3/A5 gene cluster serum HDL cholesterol levels in men and women from the
predicts post-surgery poor outcome in Taiwanese breast Polish population. Arch Med Sci. 2016;12(6):1188-1198.
cancer patients: A 10-year follow-up study. BMC Cancer.
2013;13(1):1-11. doi: 10.5114/AOMS.2016.60870
doi: 10.1186/1471-2407-13-330/TABLES/7 58. Feng DW, Ma RL, Guo H, et al. Association of APOA1
gene polymorphisms (rs670, rs5069, and rs2070665) with
49. Kolovou GD, Anagnostopoulou KK, Salpea KD, dyslipidemia in the Kazakhs of Xinjiang. Genet Mol Res.
Mikhailidis DP. The prevalence of metabolic syndrome in 2016;15(2): ???.
various populations. Am J Med Sci. 2007;333(6):362-371.
doi: 10.4238/GMR.15028094
doi: 10.1097/MAJ.0B013E318065C3A1
59. Vorobyeva MA, Azova MM, Gigani OO, Garmash IV,
50. Liu Y, Ordovas JM, Gao G, et al. Pharmacogenetic association Villevalde SV, Kobalava ZD. Genetic predictors of intensive
of the APOA1/C3/A4/A5 gene cluster and lipid responses lipid-lowering therapy efficacy and its anti-inflammatory
to fenofibrate: The genetics of lipid-lowering drugs and diet effects in very high cardiovascular risk patients. Rational
network study. Pharmacogenet Genomics. 2009;19(2):161-169. Pharmacother Cardiol. 2017;13(4):525-531.
doi: 10.1097/FPC.0B013E32831E030E doi: 10.20996/1819-6446-2017-13-4-525-531
51. Mattei J, Demissie S, Tucker KL, Ordovas JM. The APOA1/ 60. Wang X, He J, Guo H, et al. Interactions of six SNPs in
C3/A4/A5 cluster and markers of allostatic load in the APOA1 gene and types of obesity on low HDL-C disease
Boston Puerto Rican Health Study. Nutr Metab Cardiovasc in Xinjiang pastoral area of China. Lipids Health Dis.
Dis. 2011;21(11):862-870. 2017;16(1):1-7.
doi: 10.1016/J.NUMECD.2010.02.024 doi: 10.1186/S12944-017-0581-8/TABLES/4
52. Hsu MC, Chang CS, Lee KT, et al. Central obesity in males 61. Wang Y, Liu F, Li L, Deng S, He Z. The association
affected by a dyslipidemia-associated genetic polymorphism between apolipoprotein A1-C3-A5 gene cluster promoter
on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes. polymorphisms and risk of ischemic stroke in the northern
2013;3(3):e61. Chinese Han population. J Int Med Res. 2017;45(6):2042-2052.
doi: 10.1038/nutd.2013.2 doi: 10.1177/0300060517713517
53. Al-Bustan SA, Al-Serri AE, Annice BG, Alnaqeeb MA, 62. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS,
Volume 4 Issue 1 (2025) 10 doi: 10.36922/gpd.4354

